|
Talwin NxDrug - Talwin Nx The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
Active Ingredient(s) -
Naloxone Hydrochloride; Pentazocine Hydrochloride
Strength -
EQ 0.5MG BASE;EQ 50MG BASE
Applicant -
SANOFI SYNTHELABO
New Drug Application (NDA) Number -
018733
Product Number -
001
Therapeutic Equivalence (TE) Code -
AB
Approval Date -
Dec 16, 1982
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Sanofi Synthelabo Inc
Talwin Nx
Naloxone Hcl And Pentazocaine Eq 0.5mg Base;eq 50mg Base Tablet; Oral
Pentazocine And Naloxone Hydrochlorides Eq 0.5mg Base;eq 50mg Base Tablet; Oral Pentazocine And Naloxone Hydrochlorides Eq 0.5mg Base;eq 50mg Base Tablet; Oral Talwin Nx Eq 0.5mg Base;eq 50mg Base Tablet; Oral Narcan 0.4mg/ml Injectable; Injection Narcan 1mg/ml Injectable; Injection Narcan 1mg/ml Injectable; Injection Narcan 0.02mg/ml Injectable; Injection Narcan 0.4mg/ml Injectable; Injection Narcan 1mg/ml Injectable; Injection NewDrugInformation |